TheEdgeResearch
Home / Stocks / TCHBF

Tecan Group AG (TCHBF)

OTC Healthcare Medical - Diagnostics & Research
$252.06 ▲ +0.00%
Market Cap
$3.19B
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Beta
1.08
52-Wk Range
155.25-252.06
CEO
Monica Manotas
Country
CH
Currency
USD

Tecan Group AG operates in the Medical - Diagnostics & Research industry of the Healthcare sector, headquartered in Männedorf, ZH, CH. The stock last traded at $252.06, up 0.00% on the session, giving a market capitalisation of $3.19B. On trailing twelve-month figures it carries a trailing P/E of -20.88, a net margin of -12.5%. Its beta of 1.08 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-20.88
Price / Sales
2.62
Price / Book
2.01
EV / EBITDA
23.62
Gross margin
35.2%
Operating margin
5.1%
Net margin
-12.5%
Return on equity
Debt / equity
0.19
Current ratio
2.46
Dividend yield
1.6%
Payout ratio
-34.4%
Company profile
Exchange
Other OTC
Employees
3,244
IPO date
2013-04-01
Headquarters
Männedorf, ZH, CH
About Tecan Group AG

Tecan Group AG is a specialized provider of advanced laboratory instruments and comprehensive solutions, serving a diverse clientele that includes pharmaceutical and biotechnology firms, academic research institutions, and forensic and diagnostic testing facilities. The company operates through two primary divisions: the Life Sciences Business and the Partnering Business. Its extensive product portfolio features automated liquid handling systems, microplate readers and washers, various consumables, next-generation sequencing (NGS) reagents, immunoassays, microbody products, and specialized software. Noteworthy solutions include Tecan Laberwax, an innovative automation platform, and Resolvex, an intelligent sample preparation system crucial for applications in genomics, synthetic biology, drug discovery, analytical chemistry, cell biology, protein science, numerous applied markets, and ELISA solutions. Tecan also functions as a key supplier to other laboratory instrument manufacturers, providing essential components like high-precision pumps, valves, robotic arms, and development software, vital for life science research, diagnostics, and other sectors. Further offerings include Synergence, a versatile platform for automation, and the widely recognized Freedom EVO and Fluent instrument series. Established in 1980 and headquartered in Männedorf, Switzerland, Tecan Group AG maintains a significant global presence, with operations spanning Switzerland, various other European nations, North America, Asia, and other international markets.

Comparable companies

Tecan Group AG is most often compared with the following Healthcare names:

ALCANSLYDSRLFISRGSAUHFSDMHFSKAN.SW
More research on TCHBF
TCHBF technical analysis TCHBF TheEdge Score Compare against peers
Open full interactive analysis & DCF →